{
  "drug_name": "Pralidoxime",
  "url": "https://wikem.org/wiki/Pralidoxime",
  "scraped_at": "2026-01-10T08:00:22.293898",
  "sections": {
    "General": {
      "text": "Also known as 2-PAM\nType:\nAntidote\nDosage Forms:\nCommon Trade Names: Protopam",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Antidote",
          "url": "https://wikem.org/wiki/Antidote"
        }
      ]
    },
    "Adult_Dosing": {
      "text": "",
      "subsections": {
        "Organophosphate_toxicity": {
          "text": "1-2gm IV over 5-10min\nContinuous infusion of 500mg/hr if no initial response",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Organophosphate_toxicity": {
      "text": "1-2gm IV over 5-10min\nContinuous infusion of 500mg/hr if no initial response",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pediatric_Dosing": {
      "text": "",
      "subsections": {
        "Organophosphate_toxicity_2": {
          "text": "20-40mg/kg (up to 1gm) IV over 5-10min\n5-10mg/kg/hr if no initial response",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Organophosphate_toxicity_2": {
      "text": "20-40mg/kg (up to 1gm) IV over 5-10min\n5-10mg/kg/hr if no initial response",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Special_Populations": {
      "text": "Pregnancy Rating\n: C\nLactation risk\n: Unknown\nRenal Dosing\nAdult - no requirements from manufacturer, but given that it is excreted in the urine dosage reduction is recommended.\nPediatric\nHepatic Dosing\nAdult - no adjustments recommended by manufacturer.\nPediatric",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Pregnancy Rating",
          "url": "https://wikem.org/wiki/Drug_Ratings_in_Pregnancy"
        },
        {
          "text": "Lactation risk",
          "url": "https://wikem.org/wiki/Lactation_risk_categories"
        }
      ]
    },
    "Contraindications": {
      "text": "Allergy to class/drug",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Adverse_Reactions": {
      "text": "",
      "subsections": {
        "Serious": {
          "text": "Laryngospasm\nMyasthenic crisis in patients with Myasthenia gravis\nHepatitis",
          "tables": []
        },
        "Common": {
          "text": "Blurry vision\nDiplopia\nNausea\nTachycardia\nHypertension",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "Laryngospasm",
          "url": "https://wikem.org/wiki/Laryngospasm"
        }
      ]
    },
    "Serious": {
      "text": "Laryngospasm\nMyasthenic crisis in patients with Myasthenia gravis\nHepatitis",
      "subsections": {
        "Common": {
          "text": "Blurry vision\nDiplopia\nNausea\nTachycardia\nHypertension",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "Laryngospasm",
          "url": "https://wikem.org/wiki/Laryngospasm"
        }
      ]
    },
    "Common": {
      "text": "Blurry vision\nDiplopia\nNausea\nTachycardia\nHypertension",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pharmacology": {
      "text": "Half-life: Apparent: 74 to 77 minutes, IM/IV exposure: 3 to 4 hours\nMetabolism: Hepatic\nExcretion: Urine\nMechanism of Action: Displaces an organophosphate from acetylcholinesterase (if given early before irreversible enzyme binding occurs, aka \"aging\")",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "See_Also": {
      "text": "Organophosphate Toxicity",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Organophosphate Toxicity",
          "url": "https://wikem.org/wiki/Organophosphate_Toxicity"
        }
      ]
    }
  }
}